Clinical Trials Browser

Recruiting × toripalimab × Lymphoid × Clear all

NCT06170489 2025-02-28

A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)

Phase 3 Recruiting

Hodgkin Disease